Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 3, 2007

Cinpathogen and Chinese University Form Center for Clinical and Molecular Research

  • Cinpathogen, a U.S.-based bioresearch firm, has partnered with the Institute of Biomedical Sciences at Fudan University in Shanghai to form the Fudan Cinpathogen Center for Clinical and Molecular Research.

    "By integrating Western and Chinese medical research systems,” notes Richard D. Irons, Cinpathogen's CEO, “we can advance global biomedical research and help satisfy China's growing demand for high-quality healthcare."

    The Fudan-Cinpathogen Center for Clinical and Molecular Research will bring together clinical operations, diagnostic laboratories, and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems, according to the organizations. Scientists will conduct work to support diagnosis as well as protocol-driven research on the etiology, pathogenesis, and treatment of disease.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »